ACADIA Pharmaceuticals Inc.

05/02/2022 | Press release | Distributed by Public on 05/02/2022 14:07

Acadia Pharmaceuticals Announces FDA Advisory Committee Meeting to Review Resubmission of Supplemental New Drug Application for NUPLAZID® (pimavanserin) for the Treatment of[...]